方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| CHA₂DS₂-VASc 评分× | APACHE II评分× | |
|---|---|---|
| 领域 | 临床评估 | 临床评估 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2010 | 1985 |
| 提出者≠ | Gregory Y. H. Lip, Robby Nieuwlaat, et al. | William A. Knaus, et al. |
| 类型≠ | Atrial fibrillation stroke risk stratification | ICU severity and mortality prediction |
| 开创性文献≠ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ | Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985). APACHE II: a severity of disease classification system. Critical Care Medicine, 13(10), 818-829. DOI ↗ |
| 别名 | CHA2DS2VASc, Atrial fibrillation stroke risk | APACHE-II, APACHE2 |
| 相关 | 3 | 3 |
| 摘要≠ | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. | The Acute Physiology and Chronic Health Evaluation (APACHE) II score, introduced by Knaus et al. in 1985, is a 71-point severity of illness classification system for critically ill patients. It combines acute physiological parameters, age, and chronic health status to predict intensive care unit (ICU) mortality, facilitating patient risk stratification and research standardization. |
| ScholarGate数据集 ↗ |
|
|